October 1, 2024:
The Big Ten Cancer Research Consortium (Big Ten CRC) congratulates Kari Wisinski, MD, on receiving the 2024 Pat Loehrer Award for Exemplary Collaboration in Cancer Research.
The award was presented by Howard Bailey, MD, University of Wisconsin Carbone Cancer Center Director and Associate Dean of Oncology, at the 2024 Big Ten CRC Summit on September 27.
“Dr. Wisinski embodies the collaborative spirit that we value within the Big Ten CRC. Her unwavering commitment to mentorship, her dynamic leadership, and her dedication to prioritizing patients in all her endeavors make her an exemplary and deserving recipient of this award,” said Dr. Bailey.
Dr. Wisinski is the Endowed Professor of Hematology and Oncology and chief of the Division of Hematology, Medical Oncology and Palliative Care at the University of Wisconsin School of Medicine and Public Health Department of Medicine. She is Associate Director of Clinical Research and co-lead of the Breast Cancer Disease Oriented Team at the University of Wisconsin Carbone Cancer Center. Dr. Wisinski also serves as the deputy editor of Clinical Breast Cancer.
The award, created in 2021, is presented annually to an individual researcher who best demonstrates collaboration within the Big Ten CRC. It is named in honor of Patrick J. Loehrer, MD, founding visionary of the Big Ten CRC and Distinguished Professor, Joseph W. and Jackie J. Cusick Professor of Oncology, Professor of Medicine, and Program Leader of Global Oncology at Indiana University Melvin and Bren Simon Comprehensive Cancer Center. Past recipients include Dr. Loehrer (inaugural recipient) and George Weiner, MD.
Dr. Wisinski is a member of the Big Ten CRC Steering Committee and previously served as chair of the committee. She is a member and former co-chair of the Big Ten CRC Breast Cancer Working Group.
Dr. Wisinski has led two Big Ten CRC studies, including:
- BTCRC-BRE15-024: A Phase I/II, Single Arm, Non-randomized Study of Ribociclib (LEE011), a CDK 4/6 Inhibitor, in Combination with Bicalutamide, an Androgen Receptor (AR) Inhibitor, in Advanced AR+ Triple-negative Breast Cancer
- BTCRC-BRE18-337: Phase 2 Trial with Safety Run-In of Gedatolisib Plus Talazoparib in Advanced Triple Negative or BRCA1/2 Positive, HER2 Negative Breast Cancers
The Big Ten CRC congratulates Dr. Wisinski on this well-deserved honor and looks forward to her continued contributions to the consortium and the field of oncology.
About the Big Ten Cancer Research Consortium: The Big Ten Cancer Research Consortium was created in 2013 to transform the conduct of cancer research through collaborative clinical trials and observational studies that seek to improve the lives of cancer patients in the diverse communities we serve by leveraging the scientific and clinical expertise of Big Ten universities. The Big Ten Cancer Research Consortium creates a unique team research culture to drive science rapidly from ideas to treatment and prevention. Within this innovative environment, today’s research leaders collaborate with and mentor the research leaders of tomorrow. Since its founding, the Big Ten CRC has activated nearly 40 clinical trials across a wide range of cancer types, more than 1,000 participants have enrolled in Big Ten CRC studies, and more than 500 researchers have joined Big Ten CRC Clinical Trial Working Groups.
About the Big Ten Conference: The Big Ten Conference is an association of world-class universities whose member institutions share a common mission of research, graduate, professional and undergraduate teaching and public service. Founded in 1896, the Big Ten has sustained a comprehensive set of shared practices and policies that enforce the priority of academics in the lives of students competing in intercollegiate athletics and emphasize the values of integrity, fairness and competitiveness. The broad-based programs of the 18 Big Ten institutions provide direct financial support for more than 11,000 participation opportunities on 350 teams in 42 different sports. The Big Ten sponsors 28 official conference sports, 14 for men and 14 for women. For more information, visit www.bigten.org.
Subscribe to the Big Ten CRC Newsletter
X
Facebook
YouTube